87 related articles for article (PubMed ID: 12078518)
1. Redox control of cell cycle-coupled topoisomerase II alpha gene expression.
Goswami PC; Higashikubo R; Spitz DR
Methods Enzymol; 2002; 353():448-59. PubMed ID: 12078518
[No Abstract] [Full Text] [Related]
2. Cell cycle-coupled variation in topoisomerase IIalpha mRNA is regulated by the 3'-untranslated region. Possible role of redox-sensitive protein binding in mRNA accumulation.
Goswami PC; Sheren J; Albee LD; Parsian A; Sim JE; Ridnour LA; Higashikubo R; Gius D; Hunt CR; Spitz DR
J Biol Chem; 2000 Dec; 275(49):38384-92. PubMed ID: 10986283
[TBL] [Abstract][Full Text] [Related]
3. The cell cycle-coupled expression of topoisomerase IIalpha during S phase is regulated by mRNA stability and is disrupted by heat shock or ionizing radiation.
Goswami PC; Roti Roti JL; Hunt CR
Mol Cell Biol; 1996 Apr; 16(4):1500-8. PubMed ID: 8657123
[TBL] [Abstract][Full Text] [Related]
4. DNA topoisomerase II alpha gene expression under transcriptional control in etoposide/teniposide-resistant human cancer cells.
Kubo T; Kohno K; Ohga T; Taniguchi K; Kawanami K; Wada M; Kuwano M
Cancer Res; 1995 Sep; 55(17):3860-4. PubMed ID: 7641205
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the catalytic function of topoisomerase II alpha through association with RNA.
Park SW; Parrott AM; Fritz DT; Park Y; Mathews MB; Lee CG
Nucleic Acids Res; 2008 Nov; 36(19):6080-90. PubMed ID: 18820297
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the 3' untranslated region of mouse DNA topoisomerase IIalpha mRNA.
Kobayashi M; Adachi N; Koyama H
Gene; 1998 Jul; 215(2):329-37. PubMed ID: 9714832
[TBL] [Abstract][Full Text] [Related]
7. HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3' untranslated regions of cytokine and angiogenic factor mRNAs.
Nabors LB; Gillespie GY; Harkins L; King PH
Cancer Res; 2001 Mar; 61(5):2154-61. PubMed ID: 11280780
[TBL] [Abstract][Full Text] [Related]
8. 3'-Untranslated region of doublecortin mRNA is a binding target of the Musashi1 RNA-binding protein.
Horisawa K; Imai T; Okano H; Yanagawa H
FEBS Lett; 2009 Jul; 583(14):2429-34. PubMed ID: 19573529
[TBL] [Abstract][Full Text] [Related]
9. Post-transcriptional regulation of glucose transporter-1 by an AU-rich element in the 3'UTR and by hnRNP A2.
Griffin ME; Hamilton BJ; Roy KM; Du M; Willson AM; Keenan BJ; Wang XW; Nichols RC
Biochem Biophys Res Commun; 2004 Jun; 318(4):977-82. PubMed ID: 15147968
[TBL] [Abstract][Full Text] [Related]
10. Messenger RNA degradation: beginning at the end.
van Hoof A; Parker R
Curr Biol; 2002 Apr; 12(8):R285-7. PubMed ID: 11967169
[TBL] [Abstract][Full Text] [Related]
11. Application of mRNA regulatory regions to improve tumor specificity of transgene expression.
Shepelev MV; Korobko EV; Georgiev GP; Sverdlov ED; Korobko IV
Cancer Gene Ther; 2011 Sep; 18(9):682-4. PubMed ID: 21720419
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation of topoisomerase II alpha at confluence and pharmacological modulation of expression by bis-benzimidazole drugs.
Tolner B; Hartley JA; Hochhauser D
Mol Pharmacol; 2001 Apr; 59(4):699-706. PubMed ID: 11259613
[TBL] [Abstract][Full Text] [Related]
13. A polymorphism in the 3' untranslated region of the gene for tumor necrosis factor receptor 2 modulates reporter gene expression.
Puga I; Lainez B; Fernández-Real JM; Buxadé M; Broch M; Vendrell J; Espel E
Endocrinology; 2005 May; 146(5):2210-20. PubMed ID: 15677760
[TBL] [Abstract][Full Text] [Related]
14. Specificity of the STAR/GSG domain protein Qk1: implications for the regulation of myelination.
Ryder SP; Williamson JR
RNA; 2004 Sep; 10(9):1449-58. PubMed ID: 15273320
[TBL] [Abstract][Full Text] [Related]
15. p53 modulation of DNA topoisomerase IIalpha gene expression.
Joshi AA; Wang Q; Suttle DP
Cell Biochem Biophys; 2000; 33(2):209-16. PubMed ID: 11325041
[No Abstract] [Full Text] [Related]
16. Posttranscriptional control of renin synthesis: identification of proteins interacting with renin mRNA 3'-untranslated region.
Skalweit A; Doller A; Huth A; Kähne T; Persson PB; Thiele BJ
Circ Res; 2003 Mar; 92(4):419-27. PubMed ID: 12600897
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneous expression of DNA topoisomerase II alpha isoforms in tumor cell lines.
Mo YY; Beck WT
Oncol Res; 1997; 9(4):193-204. PubMed ID: 9268990
[TBL] [Abstract][Full Text] [Related]
18. Translation inhibition during cell cycle arrest and apoptosis: Mcl-1 is a novel target for RNA binding protein CUGBP2.
Subramaniam D; Natarajan G; Ramalingam S; Ramachandran I; May R; Queimado L; Houchen CW; Anant S
Am J Physiol Gastrointest Liver Physiol; 2008 Apr; 294(4):G1025-32. PubMed ID: 18292181
[TBL] [Abstract][Full Text] [Related]
19. GU-rich RNA: expanding CUGBP1 function, broadening mRNA turnover.
Kim HH; Gorospe M
Mol Cell; 2008 Feb; 29(2):151-2. PubMed ID: 18243108
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin up-regulates topoisomerase II alpha expression and affects LNCaP cell cycle.
Brevini-Gandolfi TA; Cillo F; Favetta LA; Montagna A; Motta M
Mol Cell Endocrinol; 2001 May; 176(1-2):103-10. PubMed ID: 11369449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
